InMode Ltd. reported second quarter 2026 financial results with GAAP revenues of $95.6 million, consistent with the prior year period. Consumables and service revenue increased 13% to $22.3 million, while total cash position stood at $501.1 million as of June 30, 2026. The company completed a share repurchase of 6.38 million ordinary shares for an aggregate price of $87.8 million under its existing program. Management provided full-year 2026 guidance projecting revenues between $365 million and $375 million, non-GAAP gross margins between 74% and 76%, and non-GAAP diluted EPS between $1.29 and $1.34. The filing also notes the appointment of Dr. Shlomo Nass as Chairman and Moshik Itzkovich as Chief Financial Officer effective May 19, 2026. InMode operates in the medical technology industry, developing and marketing minimally invasive radio frequency devices for plastic surgery, dermatology, and other specialties.
